Amman: A new drug has been registered in Russia to cure prostate cancer after proving its effectiveness and withstanding clinical tests, according to Russian health authorities. According to a statement, the Federal Medical-Biological Agency (FMBA) said, "The drug is used to treat patients with resistant prostate cancer with radionuclide bone metastases. "The drug has proven its effectiveness as an innovative way to treat patients suffering from this disease." Source: Jordan News Agency
Jordan Takes Action on JAC E10X Vehicle Defect
September 3, 2026
Amman: The Consumer Protection Directorate has prepared a corrective action plan to address a manufacturing defect in 2022 and 2023 JAC E10X and JAC E10X SEHOL vehicles that may cause sudden stoppage while driving. The directorate, affiliated with the…